'SI-Labeled human choriogonadotropin (5I-hCG) bound to rat ovarian receptor was solubilized in Triton X-100. By using increasing concentrations of nine different antisera specific for the individual subunits of human choriogonadotropin (hCG), free '25I-hCG or '25I-hCG-receptor complex was precipitated by double-antibody technique. The ability of any antiserum to bind to the hormone-specific ,B subunit was not affected by hCG binding to receptor, suggesting that this subunit is not directly involved with the receptor in the final state of the hormone-receptor complex. In contrast, every antiserum specific for the a subunit was dramatically inhibited in binding to the solubilized '25I-hCG-receptor complex. These results suggest that the a subunit directly interacts with the receptor, thereby masking immunoreactive sites normally available on the free hormone. Because a number of reports describe binding activity of high concentrations of immunopurified (8 subunits of hCG, we propose a two-step model for the binding of hCG to receptor and postulate separate and distinct roles for the subunits. We propose that the binding of hCG to the receptor involves a specific low-affinity initial interaction of the (3 subunit with the receptor that activates a second site for the high-affinity binding of a subunit and stabilization of the hormone-receptor complex.Lutropin (luteinizing hormone; LH), follitropin (follicle-stimulating hormone), and thyrotropin (thyrotropic hormone) are glycoprotein hormones secreted by the pituitary. Although the a subunits of these hormones are identical, each hormone binds to a different receptor. Specificity is somehow endowed by the , subunits, which are distinct for each hormone. Receptor binding and target-cell activation requires the association of both subunits because isolated subunits contain little or no activity (1). Human choriogonadotropin (hCG), a hormone secreted by the placenta during pregnancy, is a natural LH analog that shares this structure. Although the mechanisms of receptor binding and target-cell activation by these glycoprotein hormones have been extensively investigated, the exact roles of the subunits in these events are not well understood. A number of recent studies demonstrate that both subunits interact with the receptor (2-10), but they do not indicate whether either subunit has a greater role in high-affinity binding or in subsequent expression of biological activity.We have attempted to answer a portion of this question by using a number of polyclonal antisera specific for the subunits of hCG as probes to determine the relative availability of each subunit for binding to antibody after the hormone has bound to receptor. Unexpectedly, we find that all immunoreactive sites detectable on the (3 subunit of the free hormone are still available after the hormone has bound to receptor. In contrast, the number of antibody-binding sites on the a subunit are drastically decreased in the hCG-receptor complex. In light of these results, we present a two-step model f...